Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Assets Growth (3y) (2013 - 2026)

Analysis

Resmed (RMD) Assets Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.92%
Mar 31, 2026 9.37%
Dec 31, 2025 8.40%
Sep 30, 2025 17.07%
Jun 30, 2025 17.06%
Mar 31, 2025 15.54%
Dec 31, 2024 14.68%
Sep 30, 2024 15.16%
Jun 30, 2024 13.28%
Mar 31, 2024 14.12%
Dec 31, 2023 14.73%
Sep 30, 2023 13.41%
Jun 30, 2023 13.75%
Mar 31, 2023 14.18%
Dec 31, 2022 15.31%
Sep 30, 2022 7.61%
Jun 30, 2022 7.45%
Mar 31, 2022 6.17%
Dec 31, 2021 7.05%
Sep 30, 2021 15.52%